European Commission Adopts New Health Strategy

Fostering good health in an ageing population, protecting citizens from health threats and supporting dynamic health systems and new technologies are the objectives of the new health strategy adopted by the European Commission on 23 October. The White Paper, entitled "Together for Health - A Strategic Approach for the EU, 2008-2013", sets out a framework to respond to a wide range of health challenges in a comprehensive and coherent way.

"The European Union is facing new challenges. Its population is ageing fast and recent enlargements widened the health gaps between Member States," said EU Health Commissioner Markos Kyprianou. "Migration, the mobility of health professionals and patients, the risks posed by pandemics and bioterrorism, all represent additional challenges. So do globalisation and climate change. The time has come for the EU to develop a strong and comprehensive strategy on health."

The Commission underlines the importance of research to the strategy, noting that "health policy must be based on the best scientific evidence derived form sound data and information, and relevant research".

Research has an important role to play in achieving the three key objectives of the strategy. For example, our ageing population means that the development of geriatric medicine needs to be actively promoted, and we need to improve our understanding of neurodegenerative diseases such as Alzheimer's.

Meanwhile, protecting the citizen from emerging health threats will require the strengthening of mechanisms for surveillance and response to health threats, the strategy states.

Finally, the third objective concerns the promotion of dynamic health systems. "New technologies have the potential to revolutionise healthcare and health systems and to contribute to their future sustainability," the strategy reads. "eHealth, genomics and biotechnologies can improve prevention of illness, delivery of treatment, and support a shift from hospital care to prevention and primary care." However, the Commission warns that new technologies must be evaluated properly and the ethical issues relating to them need to be addressed.

On funding, the Commission notes that health research is due to be financed through its own priority in the Seventh Framework Programme (FP7) and via the new Joint Technology Initiative on Innovative Medicines. The Competitiveness and Innovation Programme (CIP) and regional funds are also cited as potential resources for research funding.

The strategy sets out 18 concrete priority actions for the next two years for both the Commission and the Member States, and further actions will be proposed throughout the strategy's lifespan.

"The new strategy will enable us to help Member States meet a wide range of common challenges based on shared principles and values, while keeping in mind our global commitments," said Commissioner Kyprianou. "Ultimately, the prosperity of the European Union largely depends on the health status of its citizens."

For further information, please visit:

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...